Specialized Therapeutic Solutions for Cholestatic Diseases in Unique Operational Environments
Legal Citation
Summary of the Inventive Concept
The inventive concept adapts the original method of treating cholestatic diseases for specific, narrow markets or unique operational environments, providing targeted therapeutic solutions for high-altitude, disaster relief, high-security, and extreme weather settings.
Background and Problem Solved
The original patent addresses the treatment of cholestatic diseases, primarily PBC and PSC. However, the original method may not be effective or practical in unique operational environments, such as high-altitude, disaster relief, high-security, or extreme weather settings, where subjects may have compromised respiratory, immune, or other systems. The new inventive concept solves this problem by providing specialized therapeutic solutions tailored to these specific environments.
Detailed Description of the Inventive Concept
The inventive concept comprises a set of specialized methods and systems for treating cholestatic diseases in unique operational environments. In a high-altitude environment, the method administers a therapeutically effective amount of a composition comprising elafibranor to a subject with a compromised respiratory system. In a disaster relief setting, the system includes a portable device for administering elafibranor and a power source operable in a low-infrastructure environment. For subjects with compromised immune systems, the method combines elafibranor with an immunomodulator. In high-security environments, the system features a secure storage unit for elafibranor and a biometric authentication device for authorized access. For subjects with a history of extreme weather exposure, the method incorporates an antioxidant with elafibranor.
Novelty and Inventive Step
The new claims introduce novel and non-obvious adaptations of the original method to address the specific challenges of unique operational environments. The inventive concept's novelty lies in its tailored approach to treating cholestatic diseases in these environments, which is not addressed by the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include variations of the composition, dosage, or administration route, as well as modifications to the portable device, power source, secure storage unit, or biometric authentication device. Additionally, the inventive concept could be adapted for other unique operational environments, such as space exploration or remote wilderness areas.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in niche markets catering to high-altitude, disaster relief, high-security, and extreme weather environments. Target industries may include military, aerospace, emergency response, and specialized healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/192 |
| A | A61 | A61K45/06 |
| A | A61 | A61P37/06 |
Original Patent Information
| Patent Number | US 11,857,523 |
|---|---|
| Title | Methods of treatment of cholestatic diseases |
| Assignee(s) | Genfit |